3 ms·

"Uncontested dominance of the US market"? How then did we get Moderna in early 2021?

by cafard 2y ago

zrn900 2y ago
Its hard to understand your argument: Pfizer monopolized the US vaccine market until the end of the lockdown as I said: > In the beginning of the COVID-19 US epidemic in March 2020, sweeping lockdowns and other aggressive measures were put in place and retained in many states until end of August of 2020 > Moderna in early 2021 You will notice that date is later than the lockdown end date. By summer 2019, Europe had around 5-6 different vaccines available. The US had only Pfizer. It remained like that until the end of the lockdown.
- theoldlove 2y ago
  Something is off here. Vaccines in summer 2019 (before covid)? Pfizer available in August 2020? Timeline is wonky. Vaccines in my memory only become broadly available April 2021 (in the US), and at that time I knew people who got Pfizer and people who got Moderna.
  - zrn900 2y ago
    I may not remember the exact dates now as I didn't ever expect this to be something that would come up in any discussion. However: > Vaccines in my memory only become broadly available Yes, that makes a difference - the vaccines that got expedited approval were provided to 'essential workers' at the time - in the US this was only Pfizer until the harshest lockdown ended. In the Eu there were 5-6 vaccines available, however Pfizer still dominated the market.
    - gnabgib 2y ago
      Pfizer was granted emergency use in the US on December 11 2020, Moderna was granted the same in the US on December 18, 2020. AstraZeneca was approved first in the UK December 30, 2020 (but due to the Sept 8 trial suspension approval was delayed in the US) https://en.wikipedia.org/wiki/History_of_COVID-19_vaccine_development https://en.wikipedia.org/wiki/History_of_COVID-19_vaccine_de... https://en.wikipedia.org/wiki/Oxford%E2%80%93AstraZeneca_COVID-19_vaccine https://en.wikipedia.org/wiki/Oxford%E2%80%93AstraZeneca_COV...
      - zrn900 2y ago
        Yet still, Pfizer ended up dominating both markets - by delaying the approval of those that could compete and the lobbying making it so that it was the one that was bulk purchased in quantity. When I meant approval, I meant the approval of any competitor who could provide at scale. None such vaccine was allowed until the quarantine ended. Even after that Pfizer was still being pushed against all competitors including cheaper American ones. So long story short - their lobby won.

"Uncontested dominance of the US market"? How then did we get Moderna in early 2021?

by cafard 2y ago

"Uncontested dominance of the US market"? How then did we get Moderna in early 2021?

Its hard to understand your argument: Pfizer monopolized the US vaccine market until the end of the lockdown as I said: > In the beginning of the COVID-19 US epidemic in March 2020, sweeping lockdowns and other aggressive measures were put in place and retained in many states until end of August of 2020 > Moderna in early 2021 You will notice that date is later than the lockdown end date. By summer 2019, Europe had around 5-6 different vaccines available. The US had only Pfizer. It remained like that until the end of the lockdown.

theoldlove 2y ago
Something is off here. Vaccines in summer 2019 (before covid)? Pfizer available in August 2020? Timeline is wonky. Vaccines in my memory only become broadly available April 2021 (in the US), and at that time I knew people who got Pfizer and people who got Moderna.
- zrn900 2y ago
  I may not remember the exact dates now as I didn't ever expect this to be something that would come up in any discussion. However: > Vaccines in my memory only become broadly available Yes, that makes a difference - the vaccines that got expedited approval were provided to 'essential workers' at the time - in the US this was only Pfizer until the harshest lockdown ended. In the Eu there were 5-6 vaccines available, however Pfizer still dominated the market.
  - gnabgib 2y ago
    Pfizer was granted emergency use in the US on December 11 2020, Moderna was granted the same in the US on December 18, 2020. AstraZeneca was approved first in the UK December 30, 2020 (but due to the Sept 8 trial suspension approval was delayed in the US) https://en.wikipedia.org/wiki/History_of_COVID-19_vaccine_development https://en.wikipedia.org/wiki/History_of_COVID-19_vaccine_de... https://en.wikipedia.org/wiki/Oxford%E2%80%93AstraZeneca_COVID-19_vaccine https://en.wikipedia.org/wiki/Oxford%E2%80%93AstraZeneca_COV...
    - zrn900 2y ago
      Yet still, Pfizer ended up dominating both markets - by delaying the approval of those that could compete and the lobbying making it so that it was the one that was bulk purchased in quantity. When I meant approval, I meant the approval of any competitor who could provide at scale. None such vaccine was allowed until the quarantine ended. Even after that Pfizer was still being pushed against all competitors including cheaper American ones. So long story short - their lobby won.